Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1459)	10/1/1998 9:48:00 PM
From: Steve Harmon	Read Replies (2) \| Respond to of 2742

Cistron's management(there is only 2) can not use the following excuses in explaining their bankrupt stock price... 1)Asian contagion...No exposure 2)Russian contagion...No exposure 3)Brazil...No exposure 4)Low in cash...Have $12.5 million total 5)Need time to understand Cistron's products...Each of the 2 officers have been at Cistron 14 freakin years. 6)Long Term Capital Hedge Fund crisis...No exposure 7)Can't initiate a stock buyback to PROTECT and increase shareholder value because we want to protect biotechs most valuable resource...JUST GAVE OUT A $100,000 BONUS. 2 OFFICERS HAVE BEEN PAID $800,000 since the IMNX settlement. 8)Biotechs are in a slump...IMNX has quadrupled since the settlement with Cistron. 9)Overall market is down...Cistron's share price went nowhere when the market was UP. There are no excuses left for Cistron's management to use...